Humacyte, Inc. (HUMA)
NASDAQ: HUMA · Real-Time Price · USD
0.9383
+0.0521 (5.88%)
At close: Feb 6, 2026, 4:00 PM EST
0.9549
+0.0166 (1.77%)
After-hours: Feb 6, 2026, 7:59 PM EST
Humacyte Employees
As of December 31, 2024, Humacyte had 220 total employees, including 218 full-time and 2 part-time employees. The number of employees increased by 35 or 18.92% compared to the previous year.
Employees
220
Change (1Y)
35
Growth (1Y)
18.92%
Revenue / Employee
$7,141
Profits / Employee
-$168,041
Market Cap
181.09M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2024 | 220 | 35 | 18.92% | 218 | 2 |
| Dec 31, 2023 | 185 | 21 | 12.80% | 183 | 2 |
| Dec 31, 2022 | 164 | 18 | 12.33% | 164 | 0 |
| Dec 31, 2021 | 146 | - | - | 145 | 1 |
Related Stocks
| Company Name | Employees |
|---|---|
| Editas Medicine | 246 |
| Innate Pharma | 174 |
| Molecular Partners AG | 153 |
| Prelude Therapeutics | 131 |
| C4 Therapeutics | 110 |
| Tenaya Therapeutics | 97 |
| Cartesian Therapeutics | 66 |
| Milestone Pharmaceuticals | 33 |
HUMA News
- 4 weeks ago - Humacyte Announces Hospital Charge Data Showing High Expense of Preventable Extremity Arterial Injury Complications - GlobeNewsWire
- 4 weeks ago - Humacyte Announces Planned Marketing Authorization Application for Symvess® in Israel - GlobeNewsWire
- 6 weeks ago - Humacyte Announces Publication of Long-Term Safety and Efficacy Results of Symvess® in Extremity Trauma Repair - GlobeNewsWire
- 7 weeks ago - Humacyte Announces Credit Facility of Up to $77.5 Million with Avenue Capital - GlobeNewsWire
- 2 months ago - Humacyte Announces Presentations at VEITHsymposium Highlighting Positive Acellular Tissue Engineered Vessel (ATEV™) Clinical Results - GlobeNewsWire
- 3 months ago - Humacyte Announces Six Presentations Scheduled for the Upcoming 52nd Annual Symposium on Vascular and Endovascular Issues, Techniques and Horizons (VEITHsymposium) - GlobeNewsWire
- 3 months ago - Humacyte, Inc. (HUMA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 3 months ago - Humacyte Announces Third Quarter 2025 Financial Results and Provides Business Update - GlobeNewsWire